Kapil Dhingra, M.B.B.S.

Kapil Dhingra, M.B.B.S.

DirectoratReplimune Group· In proxies 2023–2025

Kapil Dhingra, M.B.B.S. sits on 17 public boards.

Boards2

  • Replimune GroupDirector · 4 yr on the boardIndependentCompensation, Research & Development (Chair)—Paid as an executive
  • Black Diamond TherapeuticsDirector · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Replimune GroupPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -1%
  2. Black Diamond TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. CARGO Therapeutics Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  4. Black Diamond Therapeutics, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  5. LAVA Therapeutics B.V.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  6. Median Technologies Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  7. Advanced Accelerator Applications S.A.Public company
    • Director? – PresentNo stock prices for these years
  8. Algeta ASA, YM Biosciences Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. BioVex, Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Epitherapeutics, Exosome Diagnostics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  11. Five Prime Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  12. Mariana OncologyPublic company
    • Director? – PresentNo stock prices for these years
  13. Micromet, Inc.Public company
    • Director? – PresentNo stock prices for these years
  14. YM Biosciences Inc.Public company
    • Director? – PresentNo stock prices for these years
  15. LAVA Therapeutics N.V.Public company · 4 yr
    • Director2021 – 2025 · 4 yrNo stock prices for these years
  16. Autolus TherapeuticsPublic company · 9 yr
    • Director2014 – 2023 · 9 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?